文献速递骨质疏松与钙磷/甲状旁腺

CRTAP变异所致罕见成骨不全症的遗传分析、表型谱与功能研究

Genetic Analysis, Phenotypic Spectrum and Functional Study of Rare Osteogenesis Imperfecta Caused by CRTAP Variants.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

研究纳入两个非近亲婚配家系,评估CRTAP突变所致VII型成骨不全症患者的表型和基因型,并对一例患者骨标本进行功能研究。发现新突变c.621+1G>A可损害mRNA转录导致CRTAP蛋白截短;双等位基因突变使成骨细胞CRTAP mRNA和蛋白显著降低、骨样体积和成骨细胞数明显减少,同时I型胶原α1链Pro986脯氨酰3-羟化显著降低、骨内活动性骨形成不可见。

要点

  • VII型成骨不全症表现为早发性反复骨折、严重骨质疏松和骨畸形。
  • c.621+1G>A为新突变,可损害mRNA转录并导致CRTAP蛋白截短。
  • 双等位基因突变使成骨细胞CRTAP mRNA和蛋白显著降低、I型胶原α1链Pro986 3-羟化降低并损害骨形成。

核心结论

  • CRTAP新突变c.621+1G>A扩展了VII型成骨不全症的基因型谱。
  • CRTAP双等位基因突变c.621+1G>A和c.1153-3C>G可导致成骨细胞CRTAP mRNA降低和CRTAP蛋白缺陷,进而降低I型胶原α1链Pro986的3-羟化并损害骨形成,从而促发严重VII型成骨不全症。

研究设计与样本

  • 纳入两个非近亲婚配家系,评估其表型和基因型。
  • 骨标本取自1例成骨不全症患者和1名正常对照,均于骨科手术时获得。

主要发现

  • VII型成骨不全症患者表现为早发性反复骨折、严重骨质疏松和骨畸形。
  • 患者CRTAP中鉴定出c.621+1G>A和c.1153-3C>G突变,其中c.621+1G>A为新突变,可损害mRNA转录并导致CRTAP蛋白截短。
  • 携带c.621+1G>A和c.1153-3C>G突变的成骨不全症患者,其成骨细胞CRTAP mRNA和蛋白水平较正常对照显著降低,骨样体积和成骨细胞数较正常对照明显减少。
  • 同时伴有I型胶原α1链Pro986脯氨酰3-羟化显著降低,骨内活动性骨形成不可见。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Deficiency of cartilage-associated protein (CRTAP) can cause extremely rare autosomal recessive osteogenesis imperfecta (OI) type VII. We investigated the pathogenic mechanisms of CRTAP variants through functional studies on bones of patients with OI. METHODS: Two nonconsanguineous families with CRTAP mutations were included and their phenotypes and genotypes were evaluated. Bone specimens were obtained from 1 patient with OI and a normal control during orthopedic surgery. The impacts of the novel variant on the CRTAP transcript were confirmed. The expression levels of CRTAP mRNA and CRTAP protein were analyzed. The quantification of prolyl 3-hydroxylation in the α1 chain of type I collagen was evaluated. RESULTS: Patients with OI type VII had early-onset recurrent fractures, severe osteoporosis, and bone deformities. The c.621 + 1G > A and c.1153-3C > G mutations were identified in CRTAP in the patients with OI. The c.621 + 1G > A variant was a novel mutation that could impair mRNA transcription, leading to a truncated CRTAP protein. In a patient with c.621 + 1G > A and c.1153-3C > G mutations in CRTAP, the mRNA and protein levels of CRTAP in osteoblasts were significantly decreased and the osteoid volume and osteoblast numbers were markedly reduced compared with those in the normal control individual. This was simultaneously accompanied by significantly reduced prolyl 3-hydroxylation at Pro986 in the α1 chain of type I collagen and invisible active bone formation in bone. CONCLUSION: The novel c.621 + 1G > A mutation in CRTAP expands the genotypic spectrum of type VII OI. Biallelic mutations of c.621 + 1G > A and c.1153-3C > G in CRTAP can lead to reduced CRTAP mRNA and deficient CRTAP protein in osteoblasts, which reduces 3-hydroxylation in Pro986 of the α1 chain of type I collagen and impairs bone formation, thus contributing to severe OI type VII.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zhou B, Gao P, Hu J, et al. Genetic Analysis, Phenotypic Spectrum and Functional Study of Rare Osteogenesis Imperfecta Caused by CRTAP Variants. J Clin Endocrinol Metab. 2024. PMID: 38214665. doi:10.1210/clinem/dgae025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。